Ophthalmology
New ophthalmology study results reported from Japan, Canada and the United Kingdom
Published in Medical Device Law Weekly, March 4th, 2007
Study 1: Scientists discuss in "Frequency doubling technology perimetry after clear and yellow intraocular lens implantation" new findings in ophthalmology. In this recent study, researchers in Nara, Japan conducted a study "To evaluate the effect of intraocular lens (IOL) color on frequency doubling technology (FDT). Randomized clinical trial."
"For 26 eyes of 26 patients, FDT perimetry (24-2-threshold test) was measured three months after cataract surgery. An acrylic IOL was randomly selected from clear (VA60BB, HOYA) and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
More Articles from Medical Device Law Weekly
- Collaborations
Agreement signed between Ipsen and MSD to comarket Adrovance - Finance
Celera Group reports loss of $0.01 per share - Finance
Cooper Companies sets pricing of $350 million senior notes due 2015 - Legal Issues
Third Wave and Stratagene reach out-of-court settlement in patent litigation - Licensing Agreements
Critical Therapeutics licenses rights for vagus nerve stimulation device to Innovative Metabolics - Acute Lymphoblastic Leukemia Prognosis
Reports outline acute lymphoblastic leukemia prognosis study findings from University of Malaya, Department of Paediatrics - More from this issue of Medical Device Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
